Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26FXVH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,712
Award facts
- Contract value 100% obligated
- $32,711.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 26, 2026, the Defense Logistics Agency awarded a delivery order valued at $32,711.84 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2X200 mg/mL syringe kits. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. This award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2031 that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
CIMZIA (certolizumab pegol) is a biologic immunosuppressant used in the treatment of inflammatory conditions including rheumatoid arthritis and Crohn's disease. This delivery order represents routine pharmaceutical procurement through DLA's established supply chain to support military treatment facilities and veterans' healthcare programs. The non-set-aside competitive award underscores AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements, with the company serving as a critical vendor for the Defense Health Agency and other federal medical institutions requiring specialized and brand-name medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXVH3?
SPE2DR26FXVH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FXVH3 worth?
The government has obligated $32,712 on SPE2DR26FXVH3.
Is contract SPE2DR26FXVH3 an order under another contract?
Yes. SPE2DR26FXVH3 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVH3 competed?
The extent of competition for SPE2DR26FXVH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award